This article is more than 5 years old. Information may no longer be current.
5 stories to read for Depression Awareness Month
More than 17 million adults in the U.S. have experienced a major depressive episode, according to data from the 2017 National Survey on Drug Use and Health.
Depression is a treatable condition, but no two people are affected the same way and there is no “one-size-fits-all” treatment. To highlight Depression Awareness Month this October, Healio Psychiatry has compiled a list of stories from the last year featuring the latest research for psychiatrists and other mental health professionals.
Physical activity protects against depression
Robust evidence supports a protective relationship between objectively assessed physical activity and major depression risk, according to findings from a two-sample mendelian randomization study. Read more.
Next-generation antidepressants show promise for treatment-resistant disease
SAN FRANCISCO — In a session here, experts discussed advances in the understanding and treatment of treatment-resistant depression. Read more.
FDA approves esketamine nasal spray for hard-to-treat depression
The FDA has approved esketamine nasal spray, combined with an oral antidepressant, for the treatment of adults with treatment-resistant depression, according to a press release. Read more.
Clinicians guide to anti-inflammatory treatments for major depression
Targeting inflammation is a promising way to treat patients with major depressive disorder, according to a report in Journal of Clinical Psychiatry. Read more.
Anti-inflammatory agents improve antidepressant effects
Certain anti-inflammatory drugs improved antidepressant treatment effects and depression symptoms without increasing risk for adverse events, according to findings from a systematic review and meta-analysis. Read more.